Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging

Balci, NC; Inan, N; ANIK, YONCA; ERTÜRK, Şükrü; Ural, D; Demirci, A

doi:10.1016/j.acra.2006.04.002

Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging

Balci N., Inan N., ANIK Y., ERTÜRK Ş. M., Ural D., Demirci A.

ACADEMIC RADIOLOGY, vol.13, no.7, pp.833-839, 2006 (SCI-Expanded)

Publication Type: Article / Article
Volume: 13 Issue: 7
Publication Date: 2006
Doi Number: 10.1016/j.acra.2006.04.002
Journal Name: ACADEMIC RADIOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.833-839
Keywords: MRI, cardiac, viability, contrast agent, MYOCARDIAL-INFARCTION, LIVER, BIODISTRIBUTION
Istanbul University Affiliated: No

Abstract

Rationale and Objectives. The purpose of our study was to compare gadopentate dimeglumine (Gd-DTPA) and gadobenate dimeglumine (Gd-BOPTA) for the evaluation of myocardial infarction (MI) and in the grading transmural extent on late-contrast enhanced cardiac magnetic resonance imaging.